- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Warner Chilcott PLC
+ Add to WatchlistG3LA:GR
15.641 EUR 0.070 0.45%As of 03:20:43 ET on 05/22/2013.
Snapshot for Warner Chilcott PLC (G3LA)
| Open: | 15.645 | Day's Range: | 15.641 - 15.795 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 15.641 | 52wk Range: | 8.198 - 15.795 | 1-Yr Rtn: | +31.34% |
Key Statistics for G3LA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 5.9968 |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | 3.3560 |
| Est. PEG Ratio | 8.2715 |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 423 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 2.47% |
| Cash Dividend (USD) | 0.2500 |
| Last Dividend | 05/29/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for G3LA
Company Profile & Key Executives for G3LA
Warner Chilcott PLC is a pharmaceutical company. The Company is focused on marketing, selling, developing and manufacturing branded prescription pharmaceutical products in women's healthcare and dermatology in the United States.
| Roger M BoissonneaultPresident/CEO | W Carl ReichelPres:Pharmaceuticals |
| Paul S HerendeenExec VP/CFO | Anthony D BrunoExec VP:Corp Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
G3LA News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page